Muscle fibrillin deficiency in Marfan's syndrome myopathy

W M H Behan, C Longman, R K H Petty, P Comeglio, A H Child, M Boxer, P Foskett, D G F Harriman, W M H Behan, C Longman, R K H Petty, P Comeglio, A H Child, M Boxer, P Foskett, D G F Harriman

Abstract

Objective: To report a family with Marfan's syndrome in whom a myopathy was associated with respiratory failure; muscle biopsies from affected individuals were examined to determine whether there were abnormalities in fibrillin.

Methods: 21 family members underwent detailed clinical examination, including neurological and pulmonary assessment. Muscle biopsies in the most severely affected cases were immunostained using monoclonal antibodies to specific fibrillin components. Genomic DNA from all 21 members was analysed for mutations in the fibrillin gene, FBN1, on 15q21.

Results: 13 individuals had a C4621T base change in exon 37 of the FBN1 gene, which in four cases segregated with muscle weakness or evidence of respiratory muscle dysfunction or both. Their muscle biopsies revealed an abnormality in fibrillin immunoreactivity.

Conclusions: Abnormalities in fibrillin can be detected in muscle biopsies from patients with Marfan's syndrome who have myopathy. This pedigree, with a point mutation in FBN1, also draws attention to the potential for respiratory failure associated with myopathy.

References

    1. N Engl J Med. 1979 Apr 5;300(14):772-7
    1. Neurology. 1973 Dec;23(12):1257-68
    1. J Neurol Sci. 1980 Apr;46(1):105-12
    1. J R Soc Med. 1980 Jan;73(1):64-8
    1. Aust N Z J Med. 1984 Aug;14(4):495-9
    1. Eur Neurol. 1985;24(3):170-5
    1. J Cell Biol. 1986 Dec;103(6 Pt 1):2499-509
    1. Rev Neurol (Paris). 1986;142(8-9):703-5
    1. Am J Med Genet. 1988 Mar;29(3):581-94
    1. Nature. 1991 Jul 25;352(6333):337-9
    1. Acta Neuropathol. 1991;83(1):61-5
    1. Genomics. 1993 Aug;17(2):468-75
    1. N Engl J Med. 1994 Jul 21;331(3):148-53
    1. Nat Genet. 1994 Nov;8(3):264-8
    1. J Cell Biol. 1995 May;129(4):1165-76
    1. Adv Hum Genet. 1994;22:153-86
    1. Indian Heart J. 1994 Nov-Dec;46(6):351-2
    1. Am J Hum Genet. 1995 Jul;57(1):8-21
    1. Nat Genet. 1995 Dec;11(4):456-8
    1. Am J Med Genet. 1996 Apr 24;62(4):417-26
    1. J Histochem Cytochem. 1998 Aug;46(8):871-86
    1. Lancet. 1999 Sep 11;354(9182):878-9
    1. J Med Genet. 2000 Jan;37(1):9-25
    1. Hum Genet. 1999 Dec;105(6):587-97
    1. Annu Rev Med. 2000;51:481-510
    1. Arch Intern Med. 2001 Nov 12;161(20):2447-54
    1. Hum Mutat. 2002 Apr;19(4):443-56
    1. Neurology. 1967 Dec;17(12):1125-42
    1. Am J Med. 1970 Jan;48(1):120-6
    1. Pediatrics. 1972 Apr;49(4):574-9
    1. J Neurol Sci. 1980 Feb;45(1):43-56

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi